WallStSmart

Ridgetech, Inc. (RDGT)vsWellgistics Health, Inc. Common Stock (WGRX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ridgetech, Inc. generates 842% more annual revenue ($132.16M vs $14.03M). WGRX leads profitability with a 0.0% profit margin vs -0.9%. RDGT earns a higher WallStSmart Score of 39/100 (F).

RDGT

Hold

39

out of 100

Grade: F

Growth: 4.7Profit: 4.0Value: 6.7Quality: 8.0
Piotroski: 4/9Altman Z: 2.02

WGRX

Avoid

30

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 5.0Quality: 4.5
Piotroski: 2/9Altman Z: -15.88
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

RDGTUndervalued (+82.8%)

Margin of Safety

+82.8%

Fair Value

$10.36

Current Price

$0.83

$9.53 discount

UndervaluedFair: $10.36Overvalued

Intrinsic value data unavailable for WGRX.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

RDGT4 strengths · Avg: 9.5/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Return on EquityProfitability
30.2%10/10

Every $100 of equity generates 30 in profit

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
21.4%8/10

Revenue surging 21.4% year-over-year

WGRX1 strengths · Avg: 10.0/10
Debt/EquityHealth
-1.9210/10

Conservative balance sheet, low leverage

Areas to Watch

RDGT4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$3.39M3/10

Smaller company, higher risk/reward

Free Cash FlowQuality
$-6.74M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-0.9%1/10

Currently unprofitable

WGRX4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$6.66M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : RDGT

The strongest argument for RDGT centers on Price/Book, Return on Equity, Debt/Equity. Revenue growth of 21.4% demonstrates continued momentum.

Bull Case : WGRX

The strongest argument for WGRX centers on Debt/Equity.

Bear Case : RDGT

The primary concerns for RDGT are EPS Growth, Market Cap, Free Cash Flow.

Bear Case : WGRX

The primary concerns for WGRX are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

RDGT profiles as a growth stock while WGRX is a value play — different risk/reward profiles.

RDGT is growing revenue faster at 21.4% — sustainability is the question.

WGRX generates stronger free cash flow (-4M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

RDGT scores higher overall (39/100 vs 30/100) and 21.4% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ridgetech, Inc.

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

China Jo-Jo Drugstores, Inc. is a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company is headquartered in Hangzhou, the People's Republic of China.

Visit Website →

Wellgistics Health, Inc. Common Stock

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Wellgistics Health, Inc. is a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company is headquartered in Tampa, Florida.

Want to dig deeper into these stocks?